![Finn Cilius Nielsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Finn Cilius Nielsen
Corporate Officer/Principal presso Rigshospitalet
Profilo
Finn Cilius Nielsen is currently a Professor of Clinical Molecular Biology at Rigshospitalet.
Prior to this, he worked as a Director at Ranger Biotechnologies A and as a Principal at Scandinavian Medical Research.
Posizioni attive di Finn Cilius Nielsen
Società | Posizione | Inizio |
---|---|---|
Rigshospitalet
![]() Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Corporate Officer/Principal | - |
Precedenti posizioni note di Finn Cilius Nielsen
Società | Posizione | Fine |
---|---|---|
Scandinavian Medical Research | Corporate Officer/Principal | - |
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Ranger Biotechnologies A/S
![]() Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |
Rigshospitalet
![]() Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Health Services |
Scandinavian Medical Research |
- Borsa valori
- Insiders
- Finn Cilius Nielsen